LymphedemaV1, PascalFrancis, Curation, bibRecord, 000111

In Wuchereria bancrofti filariasis, asymptomatic microfilaraemia does not progress to amicrofilaraemic lymphatic disease : Socioeconomic differentials in health

Identifieur interne : 000111 ( PascalFrancis/Curation ); précédent : 000110; suivant : 000112

In Wuchereria bancrofti filariasis, asymptomatic microfilaraemia does not progress to amicrofilaraemic lymphatic disease : Socioeconomic differentials in health

Auteurs : Senarath Dissanayake [Émirats arabes unis]

Source :

International journal of epidemiology [ 0300-5771 ] ; 2001.

RBID : Pascal:01-0264968

Descripteurs français

Pascal (Inist)
- Filariose, Wuchereria bancrofti, Lymphoedème, Eléphantiasis, Microfilaire, Plasma sanguin, Epidémiologie, Diagnostic, Homme, Santé publique, Sri Lanka.
Wicri :
- geographic : Sri Lanka.
- topic : Homme, Santé publique.

English descriptors

KwdEn :
- Blood plasma, Diagnosis, Elephantiasis, Epidemiology, Filariosis, Human, Lymphedema, Microfilaria, Public health, Sri Lanka, Wuchereria bancrofti.

Abstract

Background In lymphatic filariasis due to Wuchereria bancrofti infections, the relationship between the natural course of infection and development of clinical disease remains controversial. The two hypotheses that are widely considered are (1) microfilaraemia represents an early stage of infection which progresses to amicrofilaraemic clinical disease and (2) microfilaraemia and clinical disease are two sequentially unrelated independent entities of the filarial infection and disease. Aim To determine whether microfilaraemic individuals develop lymphatic disease. Methods The study was conducted in Sri Lanka during the period 1982 to 1998. There were two components, firstly a cross-sectional study and then a longitudinal study. Microfilaraemia was determined by microscopic examination of night blood films. Microfilaraemia associated anti-filarial antibodies were determined by ELISA. Clinical examinations were performed to determine if the test subjects had evidence of acute and chronic lymphoedema. Results Two major observations were made. First, the incidence and development of adenolymphangitis and lymphoedema in microfilaraemic individuals were very rare and these subjects maintained asymptomatic microfilaraemic status for very long periods of time. Second, in contrast to microfilaraemic subjects, the incidence and development of lymphangitis and lymphoedema were significantly higher in amicrofilaraemic anti-filarial antibody-positive subjects. Conclusion Microfilaraemia does not represent a precondition to development of clinical disease (except male genital involvement).

A01	`01`	`1`		`@0 0300-5771`
A02	`01`			`@0 IJEPBF`
A03		`1`		`@0 Int. j. epidemiol.`
A05				`@2 30`
A06				`@2 2`
A08	`01`	`1`	`ENG`	`@1 In Wuchereria bancrofti filariasis, asymptomatic microfilaraemia does not progress to amicrofilaraemic lymphatic disease : Socioeconomic differentials in health`
A11	`01`	`1`		`@1 DISSANAYAKE (Senarath)`
A14	`01`			`@1 Faculty of Medicine and Health Sciences, UAE University, PO Box 17666 @2 Al Ain @3 ARE @Z 1 aut.`
A20				`@1 394-399`
A21				`@1 2001`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 16214 @5 354000095255780370`
A44				`@0 0000 @1 © 2001 INIST-CNRS. All rights reserved.`
A45				`@0 26 ref.`
A47	`01`	`1`		`@0 01-0264968`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 International journal of epidemiology`
A66	`01`			`@0 GBR`
C01	`01`		`ENG`	@0 Background In lymphatic filariasis due to Wuchereria bancrofti infections, the relationship between the natural course of infection and development of clinical disease remains controversial. The two hypotheses that are widely considered are (1) microfilaraemia represents an early stage of infection which progresses to amicrofilaraemic clinical disease and (2) microfilaraemia and clinical disease are two sequentially unrelated independent entities of the filarial infection and disease. Aim To determine whether microfilaraemic individuals develop lymphatic disease. Methods The study was conducted in Sri Lanka during the period 1982 to 1998. There were two components, firstly a cross-sectional study and then a longitudinal study. Microfilaraemia was determined by microscopic examination of night blood films. Microfilaraemia associated anti-filarial antibodies were determined by ELISA. Clinical examinations were performed to determine if the test subjects had evidence of acute and chronic lymphoedema. Results Two major observations were made. First, the incidence and development of adenolymphangitis and lymphoedema in microfilaraemic individuals were very rare and these subjects maintained asymptomatic microfilaraemic status for very long periods of time. Second, in contrast to microfilaraemic subjects, the incidence and development of lymphangitis and lymphoedema were significantly higher in amicrofilaraemic anti-filarial antibody-positive subjects. Conclusion Microfilaraemia does not represent a precondition to development of clinical disease (except male genital involvement).
C02	`01`	`X`		`@0 002B05E03B4D`
C02	`02`	`X`		`@0 235`
C03	`01`	`X`	`FRE`	`@0 Filariose @5 01`
C03	`01`	`X`	`ENG`	`@0 Filariosis @5 01`
C03	`01`	`X`	`SPA`	`@0 Filariosis @5 01`
C03	`02`	`X`	`FRE`	`@0 Wuchereria bancrofti @2 NS @5 02`
C03	`02`	`X`	`ENG`	`@0 Wuchereria bancrofti @2 NS @5 02`
C03	`02`	`X`	`SPA`	`@0 Wuchereria bancrofti @2 NS @5 02`
C03	`03`	`X`	`FRE`	`@0 Lymphoedème @5 04`
C03	`03`	`X`	`ENG`	`@0 Lymphedema @5 04`
C03	`03`	`X`	`SPA`	`@0 Linfedema @5 04`
C03	`04`	`X`	`FRE`	`@0 Eléphantiasis @5 07`
C03	`04`	`X`	`ENG`	`@0 Elephantiasis @5 07`
C03	`04`	`X`	`SPA`	`@0 Elefantiasis @5 07`
C03	`05`	`X`	`FRE`	`@0 Microfilaire @5 10`
C03	`05`	`X`	`ENG`	`@0 Microfilaria @5 10`
C03	`05`	`X`	`SPA`	`@0 Microfilaria @5 10`
C03	`06`	`X`	`FRE`	`@0 Plasma sanguin @5 11`
C03	`06`	`X`	`ENG`	`@0 Blood plasma @5 11`
C03	`06`	`X`	`SPA`	`@0 Plasma sanguíneo @5 11`
C03	`07`	`X`	`FRE`	`@0 Epidémiologie @5 16`
C03	`07`	`X`	`ENG`	`@0 Epidemiology @5 16`
C03	`07`	`X`	`SPA`	`@0 Epidemiología @5 16`
C03	`08`	`X`	`FRE`	`@0 Diagnostic @5 17`
C03	`08`	`X`	`ENG`	`@0 Diagnosis @5 17`
C03	`08`	`X`	`SPA`	`@0 Diagnóstico @5 17`
C03	`09`	`X`	`FRE`	`@0 Homme @5 20`
C03	`09`	`X`	`ENG`	`@0 Human @5 20`
C03	`09`	`X`	`SPA`	`@0 Hombre @5 20`
C03	`10`	`X`	`FRE`	`@0 Santé publique @5 23`
C03	`10`	`X`	`ENG`	`@0 Public health @5 23`
C03	`10`	`X`	`SPA`	`@0 Salud pública @5 23`
C03	`11`	`X`	`FRE`	`@0 Sri Lanka @2 NG @5 24`
C03	`11`	`X`	`ENG`	`@0 Sri Lanka @2 NG @5 24`
C03	`11`	`X`	`SPA`	`@0 Sri Lanka @2 NG @5 24`
C07	`01`	`X`	`FRE`	`@0 Nématodose`
C07	`01`	`X`	`ENG`	`@0 Nematode disease`
C07	`01`	`X`	`SPA`	`@0 Nematodosis`
C07	`02`	`X`	`FRE`	`@0 Helminthiase`
C07	`02`	`X`	`ENG`	`@0 Helminthiasis`
C07	`02`	`X`	`SPA`	`@0 Helmintiasis`
C07	`03`	`X`	`FRE`	`@0 Parasitose`
C07	`03`	`X`	`ENG`	`@0 Parasitosis`
C07	`03`	`X`	`SPA`	`@0 Parasitosis`
C07	`04`	`X`	`FRE`	`@0 Infection`
C07	`04`	`X`	`ENG`	`@0 Infection`
C07	`04`	`X`	`SPA`	`@0 Infección`
C07	`05`	`X`	`FRE`	`@0 Nematoda @2 NS`
C07	`05`	`X`	`ENG`	`@0 Nematoda @2 NS`
C07	`05`	`X`	`SPA`	`@0 Nematoda @2 NS`
C07	`06`	`X`	`FRE`	`@0 Nemathelminthia @2 NS`
C07	`06`	`X`	`ENG`	`@0 Nemathelminthia @2 NS`
C07	`06`	`X`	`SPA`	`@0 Nemathelminthia @2 NS`
C07	`07`	`X`	`FRE`	`@0 Helmintha @2 NS`
C07	`07`	`X`	`ENG`	`@0 Helmintha @2 NS`
C07	`07`	`X`	`SPA`	`@0 Helmintha @2 NS`
C07	`08`	`X`	`FRE`	`@0 Invertebrata @2 NS`
C07	`08`	`X`	`ENG`	`@0 Invertebrata @2 NS`
C07	`08`	`X`	`SPA`	`@0 Invertebrata @2 NS`
C07	`09`	`X`	`FRE`	`@0 Asie @2 NG`
C07	`09`	`X`	`ENG`	`@0 Asia @2 NG`
C07	`09`	`X`	`SPA`	`@0 Asia @2 NG`
C07	`10`	`X`	`FRE`	`@0 Appareil circulatoire pathologie @5 53`
C07	`10`	`X`	`ENG`	`@0 Cardiovascular disease @5 53`
C07	`10`	`X`	`SPA`	`@0 Aparato circulatorio patología @5 53`
C07	`11`	`X`	`FRE`	`@0 Lymphatique pathologie @5 54`
C07	`11`	`X`	`ENG`	`@0 Lymphatic vessel disease @5 54`
C07	`11`	`X`	`SPA`	`@0 Linfático patología @5 54`
N21				`@1 183`

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000849

Links to Exploration step

Pascal:01-0264968

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">In Wuchereria bancrofti filariasis, asymptomatic microfilaraemia does not progress to amicrofilaraemic lymphatic disease : Socioeconomic differentials in health</title>
<author><name sortKey="Dissanayake, Senarath" sort="Dissanayake, Senarath" uniqKey="Dissanayake S" first="Senarath" last="Dissanayake">Senarath Dissanayake</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Faculty of Medicine and Health Sciences, UAE University, PO Box 17666</s1>
<s2>Al Ain</s2>
<s3>ARE</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Émirats arabes unis</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">01-0264968</idno>
<date when="2001">2001</date>
<idno type="stanalyst">PASCAL 01-0264968 INIST</idno>
<idno type="RBID">Pascal:01-0264968</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000849</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000111</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">In Wuchereria bancrofti filariasis, asymptomatic microfilaraemia does not progress to amicrofilaraemic lymphatic disease : Socioeconomic differentials in health</title>
<author><name sortKey="Dissanayake, Senarath" sort="Dissanayake, Senarath" uniqKey="Dissanayake S" first="Senarath" last="Dissanayake">Senarath Dissanayake</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Faculty of Medicine and Health Sciences, UAE University, PO Box 17666</s1>
<s2>Al Ain</s2>
<s3>ARE</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Émirats arabes unis</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">International journal of epidemiology</title>
<title level="j" type="abbreviated">Int. j. epidemiol.</title>
<idno type="ISSN">0300-5771</idno>
<imprint><date when="2001">2001</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">International journal of epidemiology</title>
<title level="j" type="abbreviated">Int. j. epidemiol.</title>
<idno type="ISSN">0300-5771</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Blood plasma</term>
<term>Diagnosis</term>
<term>Elephantiasis</term>
<term>Epidemiology</term>
<term>Filariosis</term>
<term>Human</term>
<term>Lymphedema</term>
<term>Microfilaria</term>
<term>Public health</term>
<term>Sri Lanka</term>
<term>Wuchereria bancrofti</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Filariose</term>
<term>Wuchereria bancrofti</term>
<term>Lymphoedème</term>
<term>Eléphantiasis</term>
<term>Microfilaire</term>
<term>Plasma sanguin</term>
<term>Epidémiologie</term>
<term>Diagnostic</term>
<term>Homme</term>
<term>Santé publique</term>
<term>Sri Lanka</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Sri Lanka</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
<term>Santé publique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Background In lymphatic filariasis due to Wuchereria bancrofti infections, the relationship between the natural course of infection and development of clinical disease remains controversial. The two hypotheses that are widely considered are (1) microfilaraemia represents an early stage of infection which progresses to amicrofilaraemic clinical disease and (2) microfilaraemia and clinical disease are two sequentially unrelated independent entities of the filarial infection and disease. Aim To determine whether microfilaraemic individuals develop lymphatic disease. Methods The study was conducted in Sri Lanka during the period 1982 to 1998. There were two components, firstly a cross-sectional study and then a longitudinal study. Microfilaraemia was determined by microscopic examination of night blood films. Microfilaraemia associated anti-filarial antibodies were determined by ELISA. Clinical examinations were performed to determine if the test subjects had evidence of acute and chronic lymphoedema. Results Two major observations were made. First, the incidence and development of adenolymphangitis and lymphoedema in microfilaraemic individuals were very rare and these subjects maintained asymptomatic microfilaraemic status for very long periods of time. Second, in contrast to microfilaraemic subjects, the incidence and development of lymphangitis and lymphoedema were significantly higher in amicrofilaraemic anti-filarial antibody-positive subjects. Conclusion Microfilaraemia does not represent a precondition to development of clinical disease (except male genital involvement).</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0300-5771</s0>
</fA01>
<fA02 i1="01"><s0>IJEPBF</s0>
</fA02>
<fA03 i2="1"><s0>Int. j. epidemiol.</s0>
</fA03>
<fA05><s2>30</s2>
</fA05>
<fA06><s2>2</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>In Wuchereria bancrofti filariasis, asymptomatic microfilaraemia does not progress to amicrofilaraemic lymphatic disease : Socioeconomic differentials in health</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>DISSANAYAKE (Senarath)</s1>
</fA11>
<fA14 i1="01"><s1>Faculty of Medicine and Health Sciences, UAE University, PO Box 17666</s1>
<s2>Al Ain</s2>
<s3>ARE</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA20><s1>394-399</s1>
</fA20>
<fA21><s1>2001</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>16214</s2>
<s5>354000095255780370</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2001 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>26 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>01-0264968</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>International journal of epidemiology</s0>
</fA64>
<fA66 i1="01"><s0>GBR</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Background In lymphatic filariasis due to Wuchereria bancrofti infections, the relationship between the natural course of infection and development of clinical disease remains controversial. The two hypotheses that are widely considered are (1) microfilaraemia represents an early stage of infection which progresses to amicrofilaraemic clinical disease and (2) microfilaraemia and clinical disease are two sequentially unrelated independent entities of the filarial infection and disease. Aim To determine whether microfilaraemic individuals develop lymphatic disease. Methods The study was conducted in Sri Lanka during the period 1982 to 1998. There were two components, firstly a cross-sectional study and then a longitudinal study. Microfilaraemia was determined by microscopic examination of night blood films. Microfilaraemia associated anti-filarial antibodies were determined by ELISA. Clinical examinations were performed to determine if the test subjects had evidence of acute and chronic lymphoedema. Results Two major observations were made. First, the incidence and development of adenolymphangitis and lymphoedema in microfilaraemic individuals were very rare and these subjects maintained asymptomatic microfilaraemic status for very long periods of time. Second, in contrast to microfilaraemic subjects, the incidence and development of lymphangitis and lymphoedema were significantly higher in amicrofilaraemic anti-filarial antibody-positive subjects. Conclusion Microfilaraemia does not represent a precondition to development of clinical disease (except male genital involvement).</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B05E03B4D</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>235</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Filariose</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Filariosis</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Filariosis</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Wuchereria bancrofti</s0>
<s2>NS</s2>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Wuchereria bancrofti</s0>
<s2>NS</s2>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Wuchereria bancrofti</s0>
<s2>NS</s2>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Lymphoedème</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Lymphedema</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Linfedema</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Eléphantiasis</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Elephantiasis</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Elefantiasis</s0>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Microfilaire</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Microfilaria</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Microfilaria</s0>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Plasma sanguin</s0>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Blood plasma</s0>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Plasma sanguíneo</s0>
<s5>11</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Epidémiologie</s0>
<s5>16</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Epidemiology</s0>
<s5>16</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Epidemiología</s0>
<s5>16</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Diagnostic</s0>
<s5>17</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Diagnosis</s0>
<s5>17</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Diagnóstico</s0>
<s5>17</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Homme</s0>
<s5>20</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Human</s0>
<s5>20</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Hombre</s0>
<s5>20</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Santé publique</s0>
<s5>23</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Public health</s0>
<s5>23</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Salud pública</s0>
<s5>23</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Sri Lanka</s0>
<s2>NG</s2>
<s5>24</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Sri Lanka</s0>
<s2>NG</s2>
<s5>24</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Sri Lanka</s0>
<s2>NG</s2>
<s5>24</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Nématodose</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Nematode disease</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Nematodosis</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Helminthiase</s0>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Helminthiasis</s0>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Helmintiasis</s0>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Parasitose</s0>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Parasitosis</s0>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Parasitosis</s0>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Infection</s0>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Infection</s0>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Infección</s0>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Nematoda</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Nematoda</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Nematoda</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Nemathelminthia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Nemathelminthia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Nemathelminthia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Helmintha</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Helmintha</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Helmintha</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="08" i2="X" l="FRE"><s0>Invertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="08" i2="X" l="ENG"><s0>Invertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="08" i2="X" l="SPA"><s0>Invertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="09" i2="X" l="FRE"><s0>Asie</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="09" i2="X" l="ENG"><s0>Asia</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="09" i2="X" l="SPA"><s0>Asia</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="10" i2="X" l="FRE"><s0>Appareil circulatoire pathologie</s0>
<s5>53</s5>
</fC07>
<fC07 i1="10" i2="X" l="ENG"><s0>Cardiovascular disease</s0>
<s5>53</s5>
</fC07>
<fC07 i1="10" i2="X" l="SPA"><s0>Aparato circulatorio patología</s0>
<s5>53</s5>
</fC07>
<fC07 i1="11" i2="X" l="FRE"><s0>Lymphatique pathologie</s0>
<s5>54</s5>
</fC07>
<fC07 i1="11" i2="X" l="ENG"><s0>Lymphatic vessel disease</s0>
<s5>54</s5>
</fC07>
<fC07 i1="11" i2="X" l="SPA"><s0>Linfático patología</s0>
<s5>54</s5>
</fC07>
<fN21><s1>183</s1>
</fN21>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000111 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 000111 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:01-0264968
   |texte=   In Wuchereria bancrofti filariasis, asymptomatic microfilaraemia does not progress to amicrofilaraemic lymphatic disease : Socioeconomic differentials in health
}}

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le lymphœdème

In Wuchereria bancrofti filariasis, asymptomatic microfilaraemia does not progress to amicrofilaraemic lymphatic disease : Socioeconomic differentials in health

In Wuchereria bancrofti filariasis, asymptomatic microfilaraemia does not progress to amicrofilaraemic lymphatic disease : Socioeconomic differentials in health

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri